Looking further into the associations that could be found between AGR2 or AGR3 gene expression and oncogenic features, we also analysed the relationships between AGR2 and AGR3 expressions and the CNV of a set of oncogenes and TSG that are activated in cancers by copy gains (including amplifications) and losses (including deletions), respectively. The gene discussed is AGR3; the disease is cancer.